title: Setting occupational exposure limits for pharmaceuticals.
abstract: The active ingredients used in the pharmaceutical industry's products are designed to modify biological processes; thus, if not adequately controlled, they can place employees at risk. This chapter provides an historical look at the need for occupational exposure limits, as well as an overview of the limit-setting process.
authors.affiliation: Merck & Co., Inc. Whitehouse Station, New Jersey 08889-0100, USA.
authors.forename: B D
authors.initials: BD
authors.lastname: Naumann
authors.forename: E V
authors.initials: EV
authors.lastname: Sargent
mesh_terms: D000818:Animals; D001682:Biological Availability; D002986:Clinical Trials as Topic / Q000592:standards; D003142:Communication; D004282:Documentation; D004345:Drug Industry / Q000592:standards*; D004784:Environmental Monitoring / Q000379:methods; D015386:Hazardous Substances / Q000493:pharmacokinetics; D006801:Humans; D008452:Maximum Allowable Concentration; D019055:No-Observed-Adverse-Effect Level; D009784:Occupational Diseases / Q000517:prevention & control*; D016273:Occupational Exposure / Q000331:legislation & jurisprudence / Q000592:standards*; D016272:Occupational Health; D018570:Risk Assessment; D013045:Species Specificity; D018675:Toxicity Tests / Q000592:standards*; D014481:United States
chemical_list: D015386:Hazardous Substances